Abstract:The synthesis of four mononuclear palladium complexes of general formula [Pd(en)Cl(L)]NO3(en = ethylenediamine; L = pyridine (I), 4-methylpyridine (II), 4-hydroxypyridine (III) or 4-aminopyridine (IV)) has been achieved. The structure of these compounds was studied by elemental analysis, IR, far-IR and 1H NMR; complex I was analyzed by X-ray diffraction. The crystal of [Pd(en)(pyridine)Cl]NO3 is monoclinic, space group P21/c (a = 7.990(2), b = 16.058(3), c = 9.846(2) Å, β = 103.81(3)°, Z = 4, R = 0.067, Rw = 0.066). The Pd(II) atom exhibits an approximately square planar coordination with bond lengths in the range 2.017–2.042 Å for Pd-N and 2.320 Å for Pd-Cl. In order to determine the donor strength of the aromatic pyridine ligands, the stability constants of binary complex ML2+ (M = [Pd(en)(H2O)2]2+; L = pyridine, 4-Me-pyridine, 4-OH-pyridine and 4-NH2-pyridine) were determined by potentiometric pH titration in aqueous solution (T = 25°C, I = 0.1 mol 1−1 NaNO3). The results show that the stability constants of the binary complexes systematically increase with increasing pKa of the pyridines. The above four palladium complexes, [Pt(en)(pyridine)Cl]NO3 and cis-diamminedichloroplatinum(II) (cis-DDP) were assayed for cytotoxicity in vitro against the human leukemia cell line HL-60, and compounds I, II, III and cis-DDP show significant cytotoxic activity against HL-60.

Synthesis and Structure of Platinum(ii) Complexes Containing an Asymmetric Chelating Diamine 2-Morpholinoethylamine As the Carrier

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis, crystal structures and anticancer activity of pt(II) complexes with two sterically hindered 2-methylpyridine groups as the carrier

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Synthesis and Anticancer Activity of [2-Hydroxy-1,3-diaminopropane-κ2n,n′] Platinum(ii) Complexes

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

Synthesis and in Vitro Cytotoxicity of Platinum(Ii) Complexes with Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivatives As the Carrier Groups

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Structural Evidence For The Facile Chelate-Ring Opening Reactions Of Novel Platinum(Ii)-Pyridine Carboxamide Complexes

Synthesis and antitumor activities in vitro of a series of platinum (II) complexes with 2-methoxyethylamine

Synthesis and in vitro Cytotoxicity of Platinum(Ⅱ) Complexes Chelated with Chiral N-monosubstituted 1,2-Cyclohexyldiamine Derivatives

Synthesis and Cytotoxicity of Platinum(ii) Complexes of a Physiologically Active Carrier Histamine.

Crystal Structure, DNA-binding Ability and Cytotoxic Activity of Platinum(ii) 2,2′-Dipyridylamine Complexes

Synthesis and Biological Evaluation of Mixed Ammine/amine Platinum(ii) Complexes with Dicarboxylate Containing Organic Nitrate As Ligand

Synthesis, Characterization and Biological Evaluation of Platinum(II) Complexes with a Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivative

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Design, Synthesis and Biological Evaluation of Demethylcantharidate-Linked Platinum(ii) Complexes of N-monoalkyl-1R,2R-diaminocyclohexane Derivatives

Design, Synthesis and Anticancer Activity of Diam(m)ine Platinum(ii) Complexes Bearing a Small-Molecular Cell Apoptosis Inducer Dichloroacetate

Ethylenediamine-palladium(II) Complexes with Pyridine and Its Derivatives: Synthesis, Molecular Structure and Initial Antitumor Studies.